Core 1: Administrative Core
核心 1:行政核心
基本信息
- 批准号:10007602
- 负责人:
- 金额:$ 11.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAnimal ModelBasal cell carcinomaBioinformaticsBiometryChemopreventive AgentClinical TrialsClinical Trials Data Monitoring CommitteesCommunicationConsultationsCore FacilityCutaneousDoseEnsureEpithelialEpitheliumEthicsEvaluationFosteringGeneral PopulationGoalsHumanHuman ResourcesIndividualInstitutional Review BoardsKidney TransplantationLeadLeadershipMalignant Epithelial CellMalignant NeoplasmsMeasuresMethodsNational Cancer InstituteNeoplasm MetastasisOralOrgan TransplantationPhasePreventionProductivityProgram Research Project GrantsRXRReagentReportingResearchResearch PersonnelResource AllocationRetinoidsRiskScientistServicesSkin CarcinomaSquamous cell carcinomaSunscreening AgentsThe SunTimeToxic effectTransplant RecipientsUnited States National Institutes of HealthUniversitiesWisconsincancer chemopreventionclinical biomarkersmeetingsnoveloperationprogramsservice utilizationskin squamous cell carcinomasoundtanning boothstumor
项目摘要
The goal of the Administrative Core will be to coordinate the scientific, operational, and financial
operations of the entire Program Project. Dr. Craig Elmets will lead the Administrative Core and
will be assisted by the leaders of the individual projects and by the core directors. The Internal
and External Advisory Committees will offer additional advice to the Administrative Core on the
scientific direction of each of the Projects and the Scientific Cores. The Administrative Core will
provide the necessary leadership, oversight, direction, and administrative support services
necessary for the timely and ethical conduction of research related to this Program Project. In
addition, the Administrative Core will reduce the time Project and Core leaders and other
personnel need to spend on administrative details, and allow them to concentrate on the scientific
goals of the program. The Core also will facilitate interaction and communication between
components of the Program Project. The Administrative Core will accomplish this with the
following responsibilities: 1. To plan, coordinate and implement the administrative activities of the
Projects and Cores, and to maintain sound fiscal management of the Projects and Cores. 2. To
provide oversight to the core facilities by assuring high quality and adequate utilization of the
services provided, and to evaluate resource allocation to all projects and cores. 3. To promote
productive interactions between the Projects and Cores and to foster communication that will
enhance the exchange of ideas between Project and Core scientists. 4. To coordinate evaluation
by the Internal and External Advisory Committees. 5. To interface with officials at UAB, the
National Cancer Institute, the University of Wisconsin subcontract and other regulatory agencies
to ensure that there is Institutional and NIH Compliance. To coordinate regular meetings of the
Data Safety Monitoring Board and provide their reports to the IRB, the NCI and other parties to
whom these reports should be communicated. The Administrative Core will provide regular
reports to the NCI on the efficacy and toxicity of the reagents employed in the clinical biomarker
trial. 6. To coordinate biostatistical and bioinformatics activities of the core to ensure that
investigators have ready access to statistical consultation and support.
行政核心的目标将是协调科学、业务和财务方面的工作,
整个项目的运作。克雷格埃尔梅茨博士将领导行政核心,
将由各个项目的负责人和核心主任协助。内部
和外部咨询委员会将向行政核心提供关于
每个项目和科学核心的科学方向。行政核心将
提供必要的领导、监督、指导和行政支持服务
及时和合乎道德地开展与本计划项目相关的研究所必需的。在
此外,行政核心将减少项目和核心领导人和其他
人员需要花费在行政细节上,并允许他们专注于科学
方案的目标。核心还将促进
计划项目的组成部分。行政核心将通过
以下职责:1.规划、协调和执行
项目和核心,并保持项目和核心的良好财务管理。2.到
通过确保高质量和充分利用核心设施,
提供的服务,并评估所有项目和核心的资源分配情况。3.促进
项目和核心之间的有效互动,并促进沟通,
加强项目和核心科学家之间的思想交流。4.协调评价
内部和外部咨询委员会。5.为了与UAB的官员接触,
国家癌症研究所、威斯康星州大学和其他监管机构
以确保机构和NIH合规。协调委员会的定期会议,
数据安全监查委员会,并向IRB、NCI和其他各方提供报告,
这些报告应该传达给谁。行政核心将定期提供
向NCI报告临床生物标志物中所用试剂的有效性和毒性
审判6.协调核心的生物统计和生物信息学活动,以确保
调查人员可随时获得统计咨询和支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig A Elmets其他文献
Craig A Elmets的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig A Elmets', 18)}}的其他基金
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization
皮肤紫外线光损伤:通过突变 p53 免疫预防
- 批准号:
10673138 - 财政年份:2022
- 资助金额:
$ 11.42万 - 项目类别:
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization
皮肤紫外线光损伤:通过突变 p53 免疫预防
- 批准号:
10528677 - 财政年份:2022
- 资助金额:
$ 11.42万 - 项目类别:
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids 用于癌症化学预防
- 批准号:
10263919 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids 用于癌症化学预防
- 批准号:
10411342 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
项目1:UAB30对人肾移植受者皮肤癌生物标志物的评价
- 批准号:
10007598 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids 用于癌症化学预防
- 批准号:
10007585 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids 用于癌症化学预防
- 批准号:
9761479 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
项目1:UAB30对人肾移植受者皮肤癌生物标志物的评价
- 批准号:
10263921 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids 用于癌症化学预防
- 批准号:
9904076 - 财政年份:2017
- 资助金额:
$ 11.42万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 11.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists